Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 947, pseudogene (RNU6-947P) is a processed pseudogene located on chromosome 1 of Homo sapiens[1][3]. It originated via retrotransposition of U6 snRNA by LINE element activity, resulting in a noncoding genomic sequence that lacks the function of the canonical U6 small nuclear RNA[2]. Pseudogenes like RNU6-947P are generally considered genomic "fossils": they do not produce functional RNAs or proteins. The U6 snRNA is a critical part of the spliceosome machinery, but its pseudogenes, including RNU6-947P, are not involved in splicing or any recognized cellular pathway. No known diseases, drugs, or biomarker utility are associated with this sequence. As a pseudogene, it is not a target for therapeutic intervention and holds no notable clinical or pharmacological significance.
none
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 947, pseudogene (RNU6-947P).